✦ LIBER ✦

Therapeutic drug monitoring of telaprevir in chronic hepatitis C patients receiving telaprevir-based triple therapy is useful for predicting virological response

✍ Scribed by Furusyo, N.; Ogawa, E.; Murata, M.; Toyoda, K.; Ohnishi, H.; Eiraku, K.; Shimizu, M.; Harada, Y.; Mitsumoto, F.; Takayama, K.; Kainuma, M.; Okada, K.; Hayashi, J.

Book ID: 121667171
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 275 KB
Volume: 69
Category: Article
ISSN: 0305-7453
DOI: 10.1093/jac/dkt371

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

820 THERAPEUTIC DRUG MONITORING OF TELAP

820 THERAPEUTIC DRUG MONITORING OF TELAPREVIR IN CHRONIC HEPATITIS C PATIENTS RECEIVING TELAPREVIR-BASED TRIPLE THERAPY IS USEFUL FOR PREDICTING VIROLOGICAL RESPONSE AND AVOIDING TOXIC DRUG-EXPOSURE

✍ Furusyo, N.; Ogawa, E.; Murata, M.; Toyoda, K.; Ohnishi, H.; Eiraku, K.; Shimizu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Virological response rates for telaprevi

Virological response rates for telaprevir-based hepatitis C triple therapy in patients with and without HIV coinfection

✍ Martel-Laferrière, V; Brinkley, S; Bichoupan, K; Posner, S; Stivala, A; Perumals 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Optimal dosage of telaprevir in triple t

Optimal dosage of telaprevir in triple therapy for chronic hepatitis C in view of virological response and anemic severity

✍ Masumoto, A.; Yada, M.; Suzuki, H.; Senjyu, T.; Koyanagi, T.; Motomura, K. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 64 KB

P1170 VIROLOGICAL RESPONSE AT WEEK 6 OF

P1170 VIROLOGICAL RESPONSE AT WEEK 6 OF TELAPREVIR-BASED TRIPLE THERAPY IS THE MOST EFFECTIVE PREDICTOR OF CHRONIC HEPATITIS C TREATMENT OUTCOME

✍ Hiramine, S.; Ogawa, E.; Furusyo, N.; Nakamura, M.; Kajiwara, E.; Nomura, H.; Do 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Baseline factors and very early viral re

Baseline factors and very early viral response (week 1) for predicting sustained virological response in telaprevir-based triple combination therapy for Japanese genotype 1b chronic hepatitis C patients: a multicenter study

✍ Shimada, Noritomo; Toyoda, Hidenori; Tsubota, Akihito; Ide, Tatsuya; Takaguchi, 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 295 KB

Factors associated with sustained virolo

Factors associated with sustained virological response in 24-week telaprevir-based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotype

✍ Abe, Hiroshi; Tsubota, Akihito; Shimada, Noritomo; Atsukawa, Masanori; Kato, Kei 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 626 KB